IVC Evidensia

Greenhouse gas emissions & sustainability report data

📊 Latest report period: 2022-10 to 2023-09🗂️ Report periods on file: 2022-10 to 2023-09, 2021

In its 2022-10 to 2023-09 reporting, IVC Evidensia disclosed greenhouse gas emissions of 443.7K tCO2e/year (Scope 1+2+3). By scope: Scope 1: 43.9K tCO2e/year; Scope 2: 6.8K tCO2e/year; Scope 3: 392.9K tCO2e/year. Figures are as stated in the company's own report and may use different boundaries, units or methods (for example market-based vs location-based Scope 2), so compare with care.

💨
GHG Emissions
443.7K tCO2e/year (Scope 1+2+3)
2022-10 to 2023-09
⚡
Renewable Energy
85%
of total energy

📊 Emissions by Scope (2022-10 to 2023-09)

ScopeWhat it coversReported value
Scope 1Direct emissions from sources the company owns or controls (fuel combustion, company vehicles, process and fugitive emissions).43.9K tCO2e/year
Scope 2Indirect emissions from purchased electricity, steam, heat and cooling.6.8K tCO2e/year
Scope 3Other indirect emissions across the value chain (purchased goods, business travel, use of sold products, etc.).392.9K tCO2e/year

New to scopes? Read Scope 1, 2 and 3 emissions explained and market-based vs location-based Scope 2.

📈 Emissions by Report Period

Report periodHeadline emissions figure reported
2022-10 to 2023-09443.7K tCO2e/year (Scope 1+2+3)

Each row is the headline figure extracted from a different report; scope coverage and methodology can change between years.

✅ Reported Environmental Achievements

🎯 Climate & Sustainability Targets

🔜 Short-term

  • By 2025: 50% women in senior roles; 95% of suppliers signed to Code of Conduct; zero waste to landfill and 50% recycling rate in UK; 3,500 patients treated via Care Fund.

📅 Medium-term

  • By 2030: Reduce Scope 1 & 2 emissions by 50%, Scope 3 by 30%; 75% clinics with species-specific waiting rooms; reduce antibiotic prescriptions to 5%.

🔭 Long-term

  • By 2050: Net-zero emissions.

🌱 ESG Focus Areas

Climate changeDiversity, Equity, and InclusionAnimal welfare and healthSafety and well-beingAntimicrobial resistance and responsible medicine managementResponsible procurementGovernance and business ethicsAccess to healthcare

⚠️ Challenges & Risks +

  • Tracking KPI data across almost 2,500 locations in 20 countries
  • Climate change and its impact on animal health, business, and supply chain
  • Antibiotic resistance
  • Maintaining low surgical site infections while reducing antibiotic usage

📋 Report Information

Reporting Period: 2022-10 to 2023-09
Frameworks: UN Sustainable Development Goals (SDGs), Sustainability Accounting Standards Board (SASB), Task Force on Climate-related Financial Disclosures (TCFD)